The potential impact of pharmacogenetic testing on medication adherence.
Publication
, Journal Article
Haga, SB; LaPointe, NMA
Published in: Pharmacogenomics J
December 2013
Poor medication adherence is a well-known problem, particularly in patients with chronic conditions, and is associated with significant morbidity, mortality and health-care costs. Multi-faceted and personalized interventions have shown the greatest success. Pharmacogenetic (PGx) testing may serve as another tool to boost patients' confidence in the safety and efficacy of prescribed medications. Here, we consider the potential impact (positively or negatively) of PGx testing on medication-taking behavior.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Pharmacogenomics J
DOI
EISSN
1473-1150
Publication Date
December 2013
Volume
13
Issue
6
Start / End Page
481 / 483
Location
United States
Related Subject Headings
- Pharmacology & Pharmacy
- Pharmacogenetics
- Patient Compliance
- Humans
- Chronic Disease
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Haga, S. B., & LaPointe, N. M. A. (2013). The potential impact of pharmacogenetic testing on medication adherence. Pharmacogenomics J, 13(6), 481–483. https://doi.org/10.1038/tpj.2013.33
Haga, S. B., and N. M. A. LaPointe. “The potential impact of pharmacogenetic testing on medication adherence.” Pharmacogenomics J 13, no. 6 (December 2013): 481–83. https://doi.org/10.1038/tpj.2013.33.
Haga SB, LaPointe NMA. The potential impact of pharmacogenetic testing on medication adherence. Pharmacogenomics J. 2013 Dec;13(6):481–3.
Haga, S. B., and N. M. A. LaPointe. “The potential impact of pharmacogenetic testing on medication adherence.” Pharmacogenomics J, vol. 13, no. 6, Dec. 2013, pp. 481–83. Pubmed, doi:10.1038/tpj.2013.33.
Haga SB, LaPointe NMA. The potential impact of pharmacogenetic testing on medication adherence. Pharmacogenomics J. 2013 Dec;13(6):481–483.
Published In
Pharmacogenomics J
DOI
EISSN
1473-1150
Publication Date
December 2013
Volume
13
Issue
6
Start / End Page
481 / 483
Location
United States
Related Subject Headings
- Pharmacology & Pharmacy
- Pharmacogenetics
- Patient Compliance
- Humans
- Chronic Disease
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences